Aardvark Therapeutics, Inc. Common Stock (AARD) — Financial Flexibility Index
Aardvark Therapeutics, Inc. Common Stock (AARD) has a Financial Flexibility Index of -1.71x as of September 2025. Free cash flow of $-18.51 Million (operating CF $-18.52 Million minus capex $4.00K) represents -2% of total liabilities ($10.85 Million). Also explore AARD net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aardvark Therapeutics, Inc. Common Stock Financial Flexibility Index (2022–2024)
Historical Financial Flexibility Index trend for Aardvark Therapeutics, Inc. Common Stock across 3 annual periods. Check Aardvark Therapeutics, Inc. Common Stock (AARD) asset resilience to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Aardvark Therapeutics, Inc. Common Stock (2022–2024)
Year-by-year free cash flow to debt coverage for Aardvark Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see Aardvark Therapeutics, Inc. Common Stock stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.14x | $-17.98 Million | $-18.09 Million | $132.15 Million | ▼ -5.9% |
| 2023 | -0.13x | $-5.82 Million | $-5.82 Million | $45.34 Million | ▲ +45.6% |
| 2022 | -0.24x | $-10.54 Million | $-10.54 Million | $44.68 Million | — |